20
Mar

Pfizer picked up the FDA’s breakthrough therapy designation for an in-development vaccine against meningococcal disease, a common cause of meningitis, lighting the path for an accelerated approval as the drugmaker looks to expand its vaccine portfolio beyond the blockbuster Prevnar 13.

…read more

Source: Pfizer snags a ‘breakthrough’ tag for its meningitis vaccine in a race with Novartis

    

0 No comments